Webinars, Pharmaceutical

Intranasal Immunization: Promises and Challenges

Today, there are three marketed nasal vaccines available for human use but many more are in development for both human and veterinary use.
Nasal vaccination provides an alternative to the more conventional Injectable drug delivery system. Mucosal immunity can develop via interaction with immune modulators present in the nasal cavity, where the nasal associated lymphoid tissue (NALT) region plays a dominant role.

March 25, 2021 2:00 PM London / 10:00 AM New York 1 Hour
Watch the Webinar
Presented by Nektaria Karavas Dr. Julie D. Suman
25 Mar 2021

In this webinar, we provide an overview of intranasal vaccine formulations for liquid and powder administration. We then discuss the pros and cons of nasal vaccines, assess intranasal device platforms, logistical considerations that need to be taken into account, as well as present our thoughts on the opportunities that intranasal vaccination can offer.

Request Access


Requesting access to Intranasal Immunization: Promises and Challenges.

  • This field is for validation purposes and should be left unchanged.
Back To Top